A Swiss pharmaceutical company recently launched a campaign aimed at what it calls a largely overlooked but potentially serious condition: iron deficiency.
Zurich-based Vifor Pharma develops and markets
products specifically to treat iron deficiency. It kicked off its
campaign in November with a "Global Iron Deficiency Day,"
but the date served only as a springboard for a continuing effort to
raise awareness of the condition’s risks and ramifications.
deficiency is very common but often overlooked, especially in people
with chronic conditions," Prof. Maria Cappellini of the
University of Milan said. “Iron deficiency is a health-related
condition in which iron availability is insufficient to meet body
needs and therefore its timely detection and treatment is important,
because iron is essential to the functioning of multiple organs.”
Health Organization says approximately a third of the world suffers
from iron deficiency, and those most likely to be affected by it are
the elderly and people with some chronic ailments, including
congestive heart failure, kidney disease and inflammatory bowel
Swiss company holds iron deficiency to the fire
Organizations in this Story
Want to get notified whenever we write about Vifor Pharma ?
Next time we write about Vifor Pharma, we'll email you a link to the story. You may edit your settings or unsubscribe at any time.Sign-up for Alerts